A Phase Ib Trial of Neoadjuvant/adjuvant Durvalumab +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma (RCC).
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined